The Body Runs on a Battery — and Aging Is the Internal Resistance Climbing

#1

A team in Tel Aviv proposes that lifespan is not set by how fast you burn energy but by how much spare metabolic “current” you carry and how slowly your mitochondrial wiring corrodes. A single three-variable equation built on this idea — body size, mitochondrial DNA composition, and body temperature — predicts about 69% of why some mammals live 100 times longer than others.

Why does a shrew live two years and a bowhead whale over two centuries, when both run on essentially the same genes and the same cellular machinery? A new theoretical framework out of Tel Aviv-Sourasky Medical Center offers an unusually physical answer: think of a body as a battery with rising internal resistance.

The authors call it the Metabolic Scope Theory of Aging. Their core move is to stop treating the resting metabolic rate as the clock of aging and instead treat lifespan as the time it takes to exhaust a reserve. In their picture, the respiratory chain inside mitochondria behaves like an electrical circuit: the chemistry of food provides the voltage, electron flow is the current, and accumulated damage to mitochondrial DNA acts like a slowly rising internal resistance. As that resistance climbs, the system can still keep the lights on — basal energy is defended to the end — but it loses the headroom needed for the expensive work of repair, regeneration and biosynthesis. Aging, on this account, is not an energy blackout but a “managed retreat” from the ability to rebuild yourself.

The headline evidence is a single compact equation relating maximum lifespan to three measurable quantities: body mass (a stand-in for reserve capacity, or “Scope”), the guanine-cytosine content of mitochondrial DNA (a stand-in for resistance to chemical erosion, or “Stability”), and core body temperature (which sets the “Pace” of damage through ordinary reaction kinetics). Fitted across 379 mammal species, the model accounts for roughly 69% of the variation in maximum lifespan. The same temperature term independently predicts how lifespan stretches and shrinks in cold-blooded animals — flies, worms, water fleas and fish — when they are reared warmer or colder, a striking cross-check from completely separate experiments.

The framework also reorganizes familiar biology. Birds live longer than mammals their size, and the authors argue this is largely explained by their more chemically stable mitochondrial DNA rather than by anything exotic. Naked mole rats and hibernating bats win extra years by running cool. Long-lived deep-sea fish reach 150 to 200 years partly because frigid water slows the underlying chemistry.

The sober takeaway is about therapy. The authors separate damage that is reversible (redox balance, NAD status, membrane voltage) from damage that is informationally fixed (accumulated mutations). Until medicine can directly restore mitochondrial conductance, they argue, interventions can only manage the reversible layer — which is exactly why lifestyle and supplement effects in animals are real but capped. [Confidence: Medium — this is a theory paper, not an experiment.]

Actionable Insights

This is a framework paper, so its practical advice is inferential rather than tested in humans. Three usable signals emerge, with effect sizes extracted from the paper’s own numbers.

First, “Pace” — temperature. In the cross-species model, the Pace coefficient is 0.091 per degree Celsius, equivalent to an Arrhenius acceleration of about 2.5-fold per 10 C (activation energy ~73 kJ/mol). Read literally across species, each 1 C lower core temperature associates with roughly exp(0.091) = +9.5% in maximum lifespan. This is the engine behind naked mole rats (resting ~32 C) and hibernating bats. Caveat: this is an across-species correlation, not a human intervention; sustained safe cooling in humans is not demonstrated, and caloric restriction lowers human core temperature only modestly (~0.1-0.2 C).

Second, the reserve you can actually train. The paper ties lifespan to factorial aerobic scope (the ratio of maximum to resting metabolism, ~8-10x in fit young adults). It cites that this reserve falls from about 0.5%/year in the fourth decade to over 2%/year by the seventh, and that crossing roughly 18 mL/kg/min VO2max marks loss of functional independence. Exercise that preserves VO2max widens the buffer and delays threshold-crossing — though the authors are explicit that athletes gain healthspan without dominating supercentenarian statistics, so this delays decline rather than raising the ceiling.

Third, the measurement insight: dynamic “recovery” tests (heart-rate recovery after exercise, post-meal glucose clearance, phosphocreatine recovery) should track biological age better than resting bloodwork, because resting values stay normal while reserve quietly erodes.

Source:

#2

Follow-on:

Given this theory of aging, what would be the projected impact on aging of ongoing use of the ss-31 peptide in mammals after middle age?

SS-31 is a cardiolipin-binding tetrapeptide. It stabilizes cardiolipin, preserves cristae curvature, and improves respiratory supercomplex assembly and electron-transport efficiency — reducing leak/ROS as a consequence. Critically, it does nothing to mtDNA sequence. In MSTA’s vocabulary that places it squarely on the architectural impedance layer (cristae geometry, cardiolipin composition, respirasome assembly), which the paper explicitly calls “partially reversible on longer timescales.” It does not touch the informational layer (point mutations, heteroplasmy, deletions) that the theory says sets the hard ceiling.

So MSTA’s projected impact, starting in mammals after middle age:

It should lower current internal resistance and partially restore conductance — not just vent exhaust. This is what distinguishes the theory’s prediction for SS-31 from its reading of antioxidants or mitochondria-targeted catalase. Catalase is “product containment” (clears H2O2, shifts the mortality curve later without changing slope). SS-31 acts one step upstream, on a real component of Rint itself. Because it restores conductance rather than clearing a downstream product, MSTA would predict it improves all three gates at once — NAD+ regeneration (carbon gate), CoQ reoxidation under demand (electron gate), and membrane-potential-dependent work (proton gate) — which is precisely the signature the paper reserves for genuine conductance restoration rather than single-gate bypass. Expect the gains to concentrate in cardiolipin-rich, high-demand tissues: heart, skeletal muscle, kidney. The most visible readouts would be the dynamic/recovery biomarkers MSTA favors — heart-rate recovery, phosphocreatine recovery, post-load clearance — rather than resting values.

But the effect is bounded, and the boundary is the whole point. In the lifespan equation MLS ≈ reserve interval / velocity of impedance accumulation, SS-31 acts on the numerator, not the denominator. It reclaims the architectural fraction of impedance that had already accumulated — a largely one-time “recharge” — but it does not slow vZ, the rate at which informational (deamination-driven) damage piles up. That rate is set by temperature and mtDNA composition, which the peptide cannot influence.

The concrete consequences:

  • Median lifespan / healthspan: plausible meaningful gain. A rightward shift of the survival and frailty curves, of the same kind (perhaps the same order, ~10-20%) the paper attributes to MCAT mice — but arguably via a more upstream, and therefore potentially cleaner, mechanism. [Confidence: Low-Medium]
  • Maximum lifespan: little to no change. Once architectural reserve is restored to its achievable maximum, continued informational accumulation reasserts the original trajectory. MSTA would predict the Gompertz mortality slope does not durably flatten. [Confidence: Medium within the theory]

Middle age is close to the optimal window in this framework. That’s when architectural impedance has accumulated (so there’s a large reversible fraction to reclaim) but informational impedance hasn’t yet dominated the ceiling. Starting in advanced age would yield less, because by then more of the total Rint has crossed into the fixed informational layer that the peptide can’t address.

Ongoing use is the correct modality, and also a tell. Because SS-31 maintains a reversible layer rather than repairing the fixed one, the benefit is maintenance-dependent — withdraw it and architectural decay resumes. The theory predicts a front-loaded recovery followed by a maintained-but-not-rising plateau, with the underlying informational clock continuing to run underneath.

Related Reading:

1 Like